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Further comments concerning: Biochemical and 
cellular characterization of cardiac valve tissue 
after cryopreservation or antibiotic preservation 
(J THORAC CARDmVASC SUR~ 1994;108:63-7) 
To the Editor: 
Because of my own recent work on valve viability, it has 
been of particular interest to me to be involved in 
commenting on the paper by Laflg and colleagues. I am 
indeed very pleased to see this type of study being 
undertaken and published. 
In our companion letter we raised two issues that seem 
particularly controversial. There are, however, several 
aspects of Dr. Lang's article that I find questionable or 
inadequate. I suspect that it could have been substantially 
improved by rather more rigorous reviewing, and I ven- 
ture to mention some examples of my points because of 
my concern that your JOURNAL should be publishing 
potentiNly important investigations in less than optimal 
form. 
First, with respect o the analytical parameters used, 
there is too little methodologic detail, which is not sup- 
plied by the references quoted. At least some of the 
omitted details may have had a bearing on the major 
findings. For example, could there have been a differential 
sensitivity of cell types to the enzymes used for tissue 
digestion, which resulted in the survival of only endothe- 
lial cells? (Enzyme concentrations, vehicle, and tempera- 
ture and duration of digestion should have been quoted.) 
Second, the reasons for the use of certain procedures 
are not made clear. For example, why were both frozen 
and paraffin sections used for histologic study if only 
hematoxylin and eosin staining was carried out? If immu- 
nohistochemistry for cell-type recognition in the intact 
tissue and/or histochemistry for specific components had 
been performed, the use of both would be understand- 
able. Furthermore, the reference given for structural 
examination (which is from my own group) used only 
paraffin sections but a whole battery of special stains, not 
just hematoxylin and eosin. 
Third, the significance of some of the observations i
not brought out adequately. For example, the persistence 
of the marker enzyme activities despite the loss of viability 
implies that only cell fragments are necessary for this 
"metabolic activity" (not at all surprising for membrane- 
associated enzymes). It should therefore be stressed that 
"metabolic status" determined in this way is not necessar- 
ily associated with the presence of intact, viable cells and 
should never be the sole method used to assess the status 
of valves. 
Fourth, the whole approach to cell-type recognition 
seems questionable when (a) fibroblasts are not even 
considered as a normal constituent of the tissues exam- 
ined (summary paragraph, point (1), pp. 66-67), (b) the 
reference quoted as the basis of the immunochemical 
methods used is a book on the endothelial cell only, and 
(c) the nature of the cells in the intact tissue was not 
determined, as touched on earlier. 
Lois C. Armiger, PhD 
Senior Research Fellow 
The University of Auckland 
Auckland, New Zealand 
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Liver function after cardiopuimonary bypass in 
children 
To the Editor: 
I read with interest the recently published article by 
Wang and colleagues 1 concerning hyperbilirubinemia af- 
ter cardiac surgical procedures, as I have performed a 
similar but more extensive study in a pediatric popula- 
tion. 2 
With theapproval of the local hospital Ethics Commit- 
tee and with informed parental consent, I investigated 36 
children, 30 of whom underwent cardiac operations in- 
volving the use of cardiopulmonary bypass and six oi 
whom underwent cardiac operations not involving the use 
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of cardiopulmonary b pass; ages were in the range 0.01 to 
10.58 years (mean 3.14 years) and 2.75 to 12.95 years 
(mean 6.21 years), respectively. In the bypass group, 13 
patients had atrial septal defects, four had tetralogy of 
Fallot, four had ventricular septal defects, three had 
transposition (and underwent arterial switch operations), 
two had baffle leaks after previous atrial repair of trans- 
position, two had aortic stenosis, one had an atrioventric- 
ular septal defect, and one had a cortriatrium. In the 
nonbypass group, three patients had a coarctation of the 
aorta, one had a pectus excurvatum, one had a right main 
pulmonary artery stenosis (repaired with a patch), and 
one had a double outlet right ventricle combined with 
transposition (and underwent placement of a Blalock- 
Taussig shunt): 
Measurements, of aspartate transaminase (AST), ala- 
nine transaminase (ALT), alkaline phosphatase, gamma 
glutamyl transferase, bilirubin, albumin, cholesterol, and 
triglycerides were made before the operation and 6, 24, 
and 48 hours after operation. Phenylalanine clearance and 
measurement of the galactose limination capacity, both 
established and active tests of hepatic function, 3' 4 were 
carried out 6 hours after operation. Phenylalanine clear- 
ance was measured in 23 children, 18 of whom underwent 
operation involving the use of cardiopulmonary b pass. 
Galactose clearance was measured in 21 children, 17 of 
whom underwent operation involving the use of cardio- 
pulmonary bypass. 
Results showed a raised AST concentration i  five Of six 
patients who did not undergo bypass, with a raised 
preoperative l vel in one patient. The bilirubin concen- 
tration was also raised in one patient, although it had been 
abnormal before the operation, Albumin concentrations 
were reduced in three patients, triglycerides concentra- 
tions in two, and cholesterol concentrations in three; the 
triglycerides and cholesterol concentrations were elevated 
before the operation in one patient. 
In the 30 children undergoing cardiopulmonary b pass, 
AST level was elevated in 26 patients after and six patients 
before the operation, bilirubin level was elevated in six 
patients after and two patients before the operation, and 
ALT level was elevated in one patient both before and 
after the operation. Triglyceride concentrations were 
raised before and after the operation in two patients. 
Albumin concentrations were low in 29 patients after and 
in 12 patients before the operation; cholesterol concen- 
trations were low in 21 patients after and 10 patients 
before the operation. 
With the exception of patients in whom individual 
parameters were abnormal before the operation, abnor- 
malities became apparent within 6 to 24 hours and 
remained abnormal for 24 to 48 hours. 
Five children (28%) undergoing cardiopulmonary b - 
pass had a significantly lower rate of phenylalanine clear- 
ance compared with the nonbypass group (mean 12.32 + 
3.30 [standard eviation] versus 21.08 -+ 3.08 L/hr/m2;p < 
0.002, Mann-Whitney U test) and the remaining bypass 
patients (mean 21.39 _+ 5:82 L/hr/m2; p < 0.002, Mann- 
Whitney U test). The galactose limination half-life was 
significantly longer in all patients undergoing cardiopul- 
monary bypass compared with the control group (mean 
10.62 _+ 3.43 versus 6.03 + 1.30 minutes; p < 0.005, 
Mann-Whitney U test). 
In this study, the postbypass serum bilirubin concen- 
tration was raised in 20% of children, and the AST 
concentration was raised in 87%. The ALT concentra- 
tion, however, was rarely raised, suggesting that the 
increase in AST might not be the result of hepatic 
injury but could be due to other factors such as 
concurrent myocardial damage or the stress response 
because high concentrations were also common in the 
control group. Increased bilirubin concentrations could 
be due to hemolysis as suggested by Wang et al., 1 and, 
although these early changes (24 to 48 hours) could also 
be due to hypothermia or anesthetic agents, for exam- 
ple, rather than cardiopulmonary bypass itself, the 
greater the time interval between the operation and the 
onset of hepatic impairment, he greater the possibility 
that abnormalities relate to postoperative rather than 
intraoperative events. 
Changes in bromosulphalein clearance 5 after general 
surgical procedures, together with histologic evidence of 
acute inflammation from liver biopsy specimens taken 
at the end of abdominal operations, 6 both suggest hat 
cardiopulmonary b pass alone is unlikely to be the only 
explanation for hepatocellular injury during cardiac oper- 
ations. 
In conclusion, the results presented here show that, 
although frank liver failure is rarely a feature of 
corrective congenital heart disease, mild injury is com- 
mon. Furthermore, the reduction in liver function did 
not appear to be related to the complexity of the 
cardiac defect and, by implication, factors which have 
been suggested to influence the incidence of liver injury 
in adults, such as preexisting heart failure, longer 
bypass times, greater degrees of intraoperative hypo- 
thermia, and a greater isk of requiring blood transfu- 
sion. Children undergoing apparently "straightfor- 
ward" cardiac operations may therefore have just as 
much of a risk of hepatic impairment as do children 
undergoing more complex procedures. 
Ian M. Mitchell, BSc, MD, FRCS CTh 
Department of Cardiac Surgery 
Leeds General Infirmary 
Leeds, United Kingdom 
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Sites of first distant recurrence in resected non- 
small-cell lung cancer 
To the Editor: 
I read with interest the article by Yano and associates, t 
The authors hypothesize that the venous drainage of 
mediastinal lymph nodes is to the superior vena cava and 
that this may increase the likelihood of pulmonary metas- 
tasis in patients with N2 lung cancer. This proposed 
mechanism of metastatic spread is not present in patients 
with NO lung cancer; therefore a different pattern of 
distant failure is anticipated in such patients. The hypoth- 
esis is fascinating, but the authors' data are insufficient to 
justify its acceptance. 
The lung was the first site of distant recurrence in 10 of 
52 patients with NO disease and 12 of 40 with N2 disease. 
Although my knowledge of statistics i limited, a simple X z 
test to compare the frequency of lung metastasis n the 
two groups would appear to be appropriate. This test gives 
a p value of 0.23 (X z = 1.44). The authors state that the 
overall pattern of distant metastasis was different between 
patients with NO disease and those with N2 disease (p = 
0.044). Although their statement is undoubtedly true, the 
difference isprobably a reflection of the higher incidence of 
brain metastasis in the NO group (p < 0.013, X z = 6.14). A 
significant difference in the prevalence of brain metastasis 
does not necessarily support the authors' hypothesis of 
pulmonary metastatic spread from mediastinal lymph nodes. 
John D. Urschel, MD, FRCSC 
Division of Thoracic Surgery 
Roswell Park Cancer Institute 
Elm and Carlton Streets 
Buffalo, NY 14263-0001 
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Early production of interleukin-10 during 
normothermic ardiopulmonary bypass 
To the Editor: 
Cardiopulmonary bypass (CPB) is known to cause a 
systemic inflammatory response associated with an in- 
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Fig. 1. For definition of times T and H, see text. 
leukin-1 [IL-1], IL-6, and IL-8). 1' 2 Several studies uggc 
that IL-10 is an important factor in the down-regulation 
inflammatory esponses, in particular by inhibiting in vit 
proinflammatory c tokine synthesis by neutrophils (PMI 
and monocytes. 3 We hypothesized that IL-10 might 1 
produced during CPB and could represent a regulato 
mechanism controlling monocyte/PMN activation in vi~ 
We therefore measured plasma levels of IL-10 in comp~ 
ison with that of IL-6 and IL-8 in patients undergoi~ 
cardiac operations with normothermic CPB. 
Eight patients, 47.8 _+ 8.9 years of age (mean 
standard error of the mean), were studied. Patients wi 
corticosteroid therapy or suspected infectious diseas 
were excluded. Anesthesia nd CPB management we 
performed as previously described) Mean CPB and aorl 
clamping durations were 115 --- 9 and 89 + 8 minut~ 
respectively (mean --- standard error of the mean). SerJ 
blood samples were withdrawn from the radial arte 
catheter before sternotomy (TO), at the onset of Ct 
(H0), and at intervals of 1, 2, 4, 6, 10, and 24 hours (HI 
H24) after the onset of CPB. Blood samples were cc 
lected into sterile vacuum tubes with ethylenediaminet~ 
raacetic acid, immediately centrifuged, and stored 
-70~ We measured IL-10 using an enzyme-linkq 
immunosorbent assay that is specific for human IL- 
(EASIA Medgenix, Fleurus, Belgium) and IL-6 and II_ 
by enzyme-linked immunosorbent assays from Amersha 
(Biotrak, les Ulis, France). 
As shown in Fig. 1, whereas IL-10 was undetectable 
any of the plasma samples at TO and H0, plasma IL- 
levels rose in all of the patients as early as 1 hour after t] 
onset of CPB, peaked either at H1 or H2 (HI, 76.2 +- 2~ 
pg/ml; H2, 73.5 + 24.8 pg/ml; mean _+ standard error 
the mean; p = 0.01 versus H0 by Wilcoxon's matche 
paired test), and decreased at H4 (23.6 _+ 10 pg/ml). II_ 
and IL-8 levels peaked at 4 and 2 hours, respectively, aft 
the onset of CPB. By contrast with the strong positi 
